Benign Tumor-Like Conditions of the Hip

Abstract

There are numerous benign tumor-like conditions that can affect the hip, both in a systemic and a local manner. Oftentimes, tumor-like conditions are overlooked or omitted from the differential diagnosis. This can lead to a delay in diagnosis and appropriate treatment. As clinicians, it is important to be able to properly diagnose and treat these conditions in a timely fashion. Here, the authors present the incidence, characteristics, and treatment of various benign tumor-like conditions to help clinicians identify and treat these conditions.

Keywords

fibrous dysplasia - Paget's disease - pigmented villonodular synovitis - transient osteoporosis - synovial chondromatosis

• References

• 1 Bianco P, Riminucci M, Majolagbe A. , et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 2000; 15 (01) 120-128
• 2 HD Dorfman BC. Fibroosseous Lesions. In: Dorfman H. , ed. Bone Tumors First ed. St. Louis, MO: Mosby; 1998: 441-491
• 3 Kumar R, Madewell JE, Lindell MM, Swischuk LE. Fibrous lesions of bones. Radiographics 1990; 10 (02) 237-256
• 4 McCune D. Osteitis fibrosa cystica: The case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936; 52: 743-744
• 5 Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer 1994; 73 (05) 1411-1424
• 6 Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 2000; 89 (02) 188-193
• 7 Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 2000; 137 (03) 403-409
• 8 Lala R, Matarazzo P, Andreo M. , et al; Study Group for Gs alpha Protein Related Diseases of the Italian Society for Pediatric Endocrinology and Diabetes. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006; 19 (Suppl. 02) 583-593
• 9 Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PS, Hamdy NA. Outcome of long-term bisphosphonate therapy in Mccune-Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res 2017; 32 (02) 264-276
• 10 Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur. Long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg Am 1998; 80 (05) 648-658
• 11 Parvizi J, Klein GR, Sim FH. Surgical management of Paget's disease of bone. J Bone Miner Res 2006; 21 (Suppl. 02) 75-82
• 12 Delmas PD, Meunier PJ. The management of Paget's disease of bone. N Engl J Med 1997; 336 (08) 558-566
• 13 Hanna SA, Dawson-Bowling S, Millington S, Bhumbra R, Achan P. Total hip arthroplasty in patients with Paget's disease of bone: a systematic review. World J Orthop 2017; 8 (04) 357-363
• 14 Lozano-Calderon SA, Colman MW, Raskin KA, Hornicek FJ, Gebhardt M. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls. Orthop Clin North Am 2014; 45 (03) 403-416
• 15 Xie GP, Jiang N, Liang CX. , et al. Pigmented villonodular synovitis: a retrospective multicenter study of 237 cases. PLoS One 2015; 10 (03) e0121451
• 16 Steinmetz S, Rougemont AL, Peter R. Pigmented villonodular synovitis of the hip. EFORT Open Rev 2017; 1 (06) 260-266
• 17 Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore) 1980; 59 (03) 223-238
• 18 González Della Valle A, Piccaluga F, Potter HG, Salvati EA, Pusso R. Pigmented villonodular synovitis of the hip: 2- to 23-year followup study. Clin Orthop Relat Res 2001; (388) 187-199
• 19 Vastel L, Lambert P, De Pinieux G, Charrois O, Kerboull M, Courpied JP. Surgical treatment of pigmented villonodular synovitis of the hip. J Bone Joint Surg Am 2005; 87 (05) 1019-1024
• 20 Hughes TH, Sartoris DJ, Schweitzer ME, Resnick DL. Pigmented villonodular synovitis: MRI characteristics. Skeletal Radiol 1995; 24 (01) 7-12
• 21 Hardacker J, Mindell ER. Synovial chondromatosis with secondary subluxation of the hip. A case report. J Bone Joint Surg Am 1991; 73 (09) 1405-1407
• 22 Mussey Jr RD, Henderson MS. Osteochondromatosis. J Bone Joint Surg Am 1949; 31A [phone]
• 23 de Sa D, Horner NS, MacDonald A. , et al. Arthroscopic surgery for synovial chondromatosis of the hip: a systematic review of rates and predisposing factors for recurrence. Arthroscopy 2014; 30 (11) 1499-1504.e2
• 24 Murphey MD, Vidal JA, Fanburg-Smith JC, Gajewski DA. Imaging of synovial chondromatosis with radiologic-pathologic correlation. Radiographics 2007; 27 (05) 1465-1488
• 25 Evans S, Boffano M, Chaudhry S, Jeys L, Grimer R. Synovial chondrosarcoma arising in synovial chondromatosis. Sarcoma 2014; 2014: 647939
• 26 Witwity T, Uhlmann RD, Fischer J. Arthroscopic management of chondromatosis of the hip joint. Arthroscopy 1988; 4 (01) 55-56
• 27 Lee JB, Kang C, Lee CH, Kim PS, Hwang DS. Arthroscopic treatment of synovial chondromatosis of the hip. Am J Sports Med 2012; 40 (06) 1412-1418
• 28 Wuisman PI, Noorda RJ, Jutte PC. Chondrosarcoma secondary to synovial chondromatosis. Report of two cases and a review of the literature. Arch Orthop Trauma Surg 1997; 116 (05) 307-311
• 29 Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med 1987; 106 (03) 444-450
• 30 Rosen RA. Transitory demineralization of the femoral head. Radiology 1970; 94 (03) 509-512
• 31 Okada Y, Tsukada S, Saito M, Tasaki A. Simultaneous bilateral transient osteoporosis of the hip without pregnancy. Case Rep Orthop 2016; 2016: 8491461
• 32 Reddy KB, Sareen A, Kanojia RK, Prakash J. Transient osteoporosis of the hip in a nonpregnant woman. BMJ Case Rep 2015; 2015
• 33 McWalter P, Hassan A. Transient osteoporosis of the hip. Ann Saudi Med 2009; 29 (02) 146-148
• 34 Korompilias AV, Karantanas AH, Lykissas MG, Beris AE. Transient osteoporosis. J Am Acad Orthop Surg 2008; 16 (08) 480-489
• 35 Gaucher A, Colomb JN, Naoun A, Faure G, Netter P. The diagnostic value of 99m Tc-diphosphonate bone imaging in transient osteoporosis of the hip. J Rheumatol 1979; 6 (05) 574-583
• 36 McCarthy EF. The pathology of transient regional osteoporosis. Iowa Orthop J 1998; 18: 35-42
• 37 Berger CE, Kröner AH, Minai-Pour MB, Ogris E, Engel A. Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone 2003; 33 (03) 346-351
• 38 Kibbi L, Touma Z, Khoury N, Arayssi T. Oral bisphosphonates in treatment of transient osteoporosis. Clin Rheumatol 2008; 27 (04) 529-532
• 39 Schapira D, Braun Moscovici Y, Gutierrez G, Nahir AM. Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous bisphosphonates. Clin Exp Rheumatol 2003; 21 (01) 107-110